Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Department of Pediatrics, Osaka Medical College, Takatsuki, Osaka, Japan.
Pediatr Nephrol. 2017 Oct;32(10):1845-1850. doi: 10.1007/s00467-016-3462-x. Epub 2016 Jul 23.
Nail-patella syndrome (NPS) is an autosomal-dominant disease caused by LMX1B mutations and is characterized by dysplastic nails, absent or hypoplastic patellae, elbow dysplasia, and iliac horns. Renal involvement is the major determinant of the prognosis for NPS. Patients often present with varying degrees of proteinuria or hematuria, and can occasionally progress to chronic renal failure. Recent genetic analysis has found that some mutations in the homeodomain of LMX1B cause isolated nephropathy without nail, patellar or skeletal abnormality (LMX1B-associated nephropathy). The classic term "nail-patella syndrome" would not represent disease conditions in these cases. This review provides an overview of NPS, and highlights the molecular genetics of NPS nephropathy and LMX1B-associated nephropathy. Our current understanding of LMX1B function in the pathogenesis of NPS and LMX1B-associated nephropathy is also presented, and its downstream regulatory networks discussed. This recent progress provides insights that help to define potential targeted therapeutic strategies for LMX1B-associated diseases.
指甲髌骨综合征(NPS)是一种常染色体显性遗传病,由 LMX1B 基因突变引起,其特征为畸形指甲、髌骨缺失或发育不全、肘发育不良和髂骨嵴。肾脏受累是 NPS 预后的主要决定因素。患者常表现出不同程度的蛋白尿或血尿,偶尔可进展为慢性肾衰竭。最近的遗传分析发现,LMX1B 同源域的某些突变导致孤立性肾病而无指甲、髌骨或骨骼异常(LMX1B 相关肾病)。在这些情况下,经典术语“指甲髌骨综合征”不能代表疾病情况。本综述概述了 NPS,并强调了 NPS 肾病和 LMX1B 相关肾病的分子遗传学。还介绍了我们目前对 LMX1B 在 NPS 和 LMX1B 相关肾病发病机制中的功能的理解,并讨论了其下游调控网络。这些最新进展提供了有助于确定针对 LMX1B 相关疾病的潜在靶向治疗策略的见解。